STAT+: Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharma
Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Exclusive: European VC Forbion hires Dyne CEO, expands into US
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about EMA plans for GLP-1 shortages, Walgreens store closings, and more
Good morning, everyone, and how are you today? The heat continues to rise here on…
FDA issues long-awaited draft guidance for enrolling more people of color in clinical trials
The Food and Drug Administration has drafted guidance aimed at getting drug companies and medical…
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
WASHINGTON — As weight loss medications have exploded in popularity, a bill to allow Medicare…
Intellia says its CRISPR-based therapy can be redosed
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about rejection of an AbbVie Parkinson’s drug, PBM markups on mail order, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
One firm, two conflicting takes on Alnylam’s HELIOS-B
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Novo’s Wegovy approval in China, a Merck KGaA cancer trial failure, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: We’re reading about a plan for Medicare coverage of Wegovy, an Alnylam heart drug, and more
Good morning, everyone, to another working week. We hope the weekend respite was relaxing and…
The findings from Alnylam’s highly anticipated readout
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests
WASHINGTON — A House panel is exploring holding a vote on scaled-back versions of two…
Can JAK inhibitors bolster checkpoint inhibitors?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly takes more actions against unapproved versions of Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about an ‘unaffordable’ Novartis drug, a new patent office rule, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?
In a bid to prevent the patent system from being abused, the U.S. Patent and…
STAT+: Colorado state board decides a pricey Novartis medicine is unaffordable
A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans…
STAT+: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more
And so, another working week will soon draw to a close. Not a moment too…
J.P. Morgan has officially jumped into early stage biotech investing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case
On Thursday, the Supreme Court rejected an effort by anti-abortion doctors to bar the mailing…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a Pfizer drug for Duchenne, bird flu vaccines for cows, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea
WASHINGTON — Both President Biden and former President Trump love to claim credit for getting…
.jpg)
STAT+: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried
LONDON — A major shakeup in how the benefits of medicines are assessed in Europe…
STAT+: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in phase 3 trial
Pfizer said Wednesday afternoon that a closely watched gene therapy for Duchenne muscular dystrophy failed…
What do Parkinson’s and obesity have in common?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Sanders dogging Novo Nordisk, Teva patents, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
Watch: How pharmacy benefit managers influence drug pricing
This is Part 2 of “Behind the Counter,” an in-depth video series demystifying the complex…
Watch: The role of PBMs, patents, and public health in drug pricing
This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex…
Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices
WASHINGTON — Senate health committee chair Bernie Sanders has called a vote to subpoena the…
Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, an EU contract for bird flu vaccine, and more
Greetings from London, with STAT reporter Andrew Joseph here filling in for Ed. We’re dealing…
STAT+: Pharmalittle: We’re reading about a Moderna Covid-flu vaccine, a paused Pfizer study, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect…
Vanda Pharmaceuticals has another suitor
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, the GSK-Elsie deal, and more
Good morning, Jason Mast here filling in for Ed. Today, we’re sipping a hot cup…
STAT+: Pharmalittle: We’re reading about the aftermath of FDA vote on MDMA, rising pharma layoffs, and more
Top of the morning to you, and a fine one it is, despite the gray…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Psychedelics companies see FDA panel’s vote as a growth opportunity, not a roadblock
A day after a panel of advisers to the Food and Drug Administration expressed deep…
STAT+: Pharmalittle: We’re reading about MDMA ‘no’ votes, a Gilead settlement, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Student group that ranked med schools over industry conflicts votes to accept pharma funding
An organization devoted to educating future doctors about conflicts of interest will now accept industry…
STAT+: Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits
Gilead Sciences agreed in principle to pay $40 million to more than 2,600 AIDS patients…
ASCO Takeaways: Winners, snoozers, the China question and the art of cancer care
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too
Amid rising concern over prescription drug shortages, a new report finds that the number of…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…